Ovarian Cancer Support – A New Program for Women Battling Cancer
- Last Updated: August 13th, 2023
Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
Legally Reviewed
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
Fact-Checked
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Ovarian Cancer Support – A New Program for Women Battling Cancer
New York City’s Mount Sinai Hospital recognizes that women experiencing an ovarian cancer diagnosis need ovarian cancer support because it can be an isolating and scary diagnosis.
In response, the hospital created the Woman to Woman program to provide one-to-one peer mentoring and support to patients who are fighting gynecologic cancers – from those who have been through it.
“A person who can provide the best support to someone who is newly diagnosed is someone who has been in that seat,” said Rachel Justus, licensed clinical social worker and program coordinator for Woman to Woman.
Patients are given support in whatever way they choose, from email and phone interactions to having someone accompany them to chemotherapy treatment sessions.
Ovarian cancer is the deadliest form of reproductive cancer:
- About 22,280 women each year receive a new ovarian cancer diagnosis.
- A woman’s risk of getting ovarian cancer is about one in 75, and her lifetime chance of dying from the disease is one in 100.
- Approximately 75 percent of women with ovarian cancer have stage 3 or 4 of the disease.
- The five-year survival rate for stage 3 and 4 ovarian cancer ranges from 17 to 39 percent, according to the American Cancer Society.
- Medical evidence suggests that women who use talcum powder for feminine hygiene have a greater risk of developing ovarian cancer.
Thousands of women across the nation have filed suit against Johnson & Johnson for failing to warn consumers of the possible link between ovarian cancer and the company’s baby powder.
Two of those lawsuits have resulted in a finding of liability and damage orders:
- In February 2016, a jury ordered J&J to pay $72 million to the family of a woman who died from ovarian cancer in October 2015.
- On May 1, a jury ordered J&J to pay $55 million to a South Dakota woman who survived ovarian cancer.
Both women used the company’s talc-based powders in their genital areas.
A recent study from Brigham and Women’s Hospital in Boston has found that women who regularly used talc in their genital area, sanitary napkins, tampons, and underwear had a 33 percent higher risk of developing ovarian cancer.
Table of Contents
Experienced Attorney & Legal SaaS CEO
With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
